TipRanks
Connect Biopharma Holdings (CNTB)
NASDAQ:CNTB
US Market
CNTB
Connect Biopharma Holdings
RESEARCH TOOLSreports
Want to see CNTB full AI Analyst Report?

Connect Biopharma Holdings (CNTB) Stock News & Sentiment

236 Followers
3 Penny Stocks on Investors’ Radar, October 1
Premium
Market News
3 Penny Stocks on Investors’ Radar, October 1
9d ago
TGE
CNTB
Why Is Penny Stock Connect Biopharma (CNTB) Up 98% Today?
Premium
Market News
Why Is Penny Stock Connect Biopharma (CNTB) Up 98% Today?
10d ago
CNTB
Connect Biopharma reports positive Phase 2 COPD results
Premium
Company Announcements
Connect Biopharma reports positive Phase 2 COPD results
10d ago
8K
CNTB
Buy Rating Maintained on CNTB as Rademikibart Data Supports Upside; $7 Price Target Reiterated
Premium
Ratings
Buy Rating Maintained on CNTB as Rademikibart Data Supports Upside; $7 Price Target Reiterated
23d ago
CNTB
Connect Biopharma reports positive Phase 2 asthma results
Premium
Company Announcements
Connect Biopharma reports positive Phase 2 asthma results
25d ago
8K
CNTB
CNTB: Buy Rating Reiterated with Unchanged $7 Price Target Ahead of Seabreeze Trial Catalysts
Premium
Ratings
CNTB: Buy Rating Reiterated with Unchanged $7 Price Target Ahead of Seabreeze Trial Catalysts
29d ago
CNTB
Buy Rating Reiterated on CNTB as Clinical Derisking Looms and Risk/Reward Remains Attractive; $10 Price Target Maintained
Premium
Ratings
Buy Rating Reiterated on CNTB as Clinical Derisking Looms and Risk/Reward Remains Attractive; $10 Price Target Maintained
2M ago
CNTB
More CNTB News >

CNTB News on the Web

Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), Connect Biopharma Holdings (CNTB) and Helus Pharma (HELP)
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: Johnson & Johnson (JNJ), Wave Life Sciences (WVE)
TipRanks News
Bullish
Connect Biopharma Holdings Ltd Conference Call Transcript
GuruFocus News
Neutral
CNTB jumps after Phase 2 COPD trial reports 100% reduction in return ED/hospital visits at one month
Market Chameleon
Neutral
Connect Biopharma reports positive Phase 2 COPD results
TipRanks News
Neutral
Connect Biopharma (CNTB) Misses Key Asthma Trial Goal. Can its Drug Still Move Forward?
Insider Monkey
Neutral
Connect Biopharma price target lowered to $5 from $8 at Oppenheimer
TipRanks News
Bullish
Connect Biopharma price target lowered to $6 from $7 at Canaccord
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
CNTB
Sector Average
Media Buzz
This Week1 articles
Weekly Average6 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CNTB’s Media Buzz Sentiment?
1 articles about CNTB were published this week. In an average week, 6 articles are published.
    What is CNTB’s weekly average amount of articles?
    In an average week, 6 articles about CNTB are published.
      What is CNTB’s News Sentiment?
      100% of articles about CNTB were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        CMXHFCSL
        RZLTRezolute
        AMGNAmgen
        PMCUFPro Medicus Limited
        ABTAbbott Laboratories
        Showing the stocks with the most bullish news sentiment over the past week